|
| 特征 |
组1 |
组2 |
| 辅助ADT |
没有辅助ADT |
|
| 病人的数量 |
86年 |
86年 |
| 平均年龄(岁) |
66.2 |
66.6 |
| 平均随访(个月) |
69年 |
66年 |
| 意思是PSA, ng / mL(范围) |
31.5 (3 - 119) |
28.4 (2.78 -159) |
|
| 1997 TNM临床分期,((%)) |
|
|
| ≤cT2 |
36 (41.8%) |
48 (55.8%) |
| cT3 |
49 (57.0%) |
37 (43.0%) |
| cT4 |
1 (1.2%) |
1 (1.2%) |
|
| 活检格里森评分(数量(%)) |
|
|
| ≤6 |
36 (41.8%) |
44 (51.2%) |
| 7 |
39 (45.3%) |
32 (37.2%) |
| ≥8 |
11 (12.9%) |
10 (11.6%) |
|
| 病理学研究。阶段,1997 TNM ((%)) |
|
|
| pT2 |
4 (4.7%) |
9 (10.5%) |
| pT3a |
28 (32.5%) |
29 (33.7%) |
| pT3b |
50 (58.1%) |
45 (52.3%) |
| pT4 |
4 (4.7%) |
3 (3.5%) |
|
| 病理学研究。格里森评分(数量(%)) |
|
|
| ≤6 |
34 (39.5%) |
34 (39.5%) |
| 7 |
39 (45.4%) |
39 (45.4%) |
| ≥8 |
13 (15.1%) |
13 (15.1%) |
|
| 外科利润率(数量(%)) |
|
|
| 积极的 |
62例(72.1%) |
66例(76.7%) |
| 负 |
24 (27.9%) |
20 (23.3%) |
|
| 抢救治疗 |
|
|
| ADT |
0 (0.0%) |
25 (29.1%) |
| 放射治疗 |
3 (3.5%) |
9 (10.5%) |
|
|
